logo logo

Key Industries


  • 日期:2019-11-01

Source: Industrial Development Bureau, MOEA
Last Updated on: 2019/09/30


I. Policy Initiatives

In order to build Taiwan as a pivotal center for the biomedical industry in the Asia-Pacific region, Taiwan launched the "biomedical industry innovation promotion program" in November 2016. The following are options for foreign companies to locate or collaborate with local companies:

1. National Biotechnology Park​

To accommodate the development of translational medicine research, the Innovation Incubation Center has been set up in the Nangang National Biotechnology Park, and other institutions are also included, such as the National Laboratory Animal Center (NLAC), the Development Center for Biotechnology (DCB), and the Taiwan Food and Drug Administration. Therefore, the companies here have access to the startups in the biomedical field to seek more collaborative opportunities. Besides, in the Park, the resources are available to provide one-stop assistance in terms of clinical trials, commercialization of R&D results, and information on regulatory restrictions, etc. 

2. Hsinchu Biomedical Science Park​

Inside the Park are the "Biomedical Technology and Product Research and Development Center", the "Industry and Incubation Center", and the "Hsinchu Biomedical Science Park Hospital". These three major centers share R&D resources and take advantage of their adjacency to the Hsinchu Science Park. Businesses based in the Park can join hands with the information and communication industry in the surroundings while engaging themselves in biomedical technology fundamental and translational medicine research (refer to Figure 1).